Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

A Jiménez-Sánchez, P Cybulska, KLV Mager… - Nature Genetics, 2020 - nature.com
In metastatic cancer, the degree of heterogeneity of the tumor microenvironment (TME) and
its molecular underpinnings remain largely unstudied. To characterize the tumor–immune …

Molecular profiling and molecular classification of endometrioid ovarian carcinomas

P Cybulska, ADC Paula, J Tseng, MM Leitao Jr… - Gynecologic …, 2019 - Elsevier
Objective Endometrioid ovarian carcinomas (EOCs) comprise 5–10% of all ovarian cancers
and commonly co-occur with synchronous endometrioid endometrial cancer (EEC). We …

Extracts of Canadian first nations medicinal plants, used as natural products, inhibit Neisseria gonorrhoeae isolates with different antibiotic resistance profiles

P Cybulska, SD Thakur, BC Foster… - Sexually transmitted …, 2011 - journals.lww.com
Background: Neisseria gonorrhoeae (Ng) has developed resistance to most antimicrobial
agents and the antibiotics recommended for therapy are restricted, for the most part, to third …

Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project

…, SE Ferguson, T May, L Hogen, P Cybulska… - International Journal of …, 2022 - ijgc.bmj.com
Objectives Same day discharge after minimally invasive hysterectomy has been shown to
be safe and feasible. We designed and implemented a quality improvement perioperative …

Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening

…, S Lheureux, A Sayad, P Cybulska… - Proceedings of the …, 2021 - National Acad Sciences
High-grade serous tubo-ovarian carcinoma (HGSC) is a major cause of cancer-related
death. Treatment is not uniform, with some patients undergoing primary debulking surgery …

Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status

M Stasenko, P Cybulska, N Feit, V Makker, J Konner… - Gynecologic …, 2019 - Elsevier
… Author links open overlay panelMarina Stasenko a , Paulina Cybulska a , Noah Feit b , Vicky
Paulina Cybulska: Analysis and interpretation of data; drafting of article; final approval of …

Indications for and complications of transfusion and the management of gynecologic malignancies

P Cybulska, C Goss, WP Tew, R Parameswaran… - Gynecologic …, 2017 - Elsevier
Anemia, which is highly prevalent in oncology patients, is one of the most established negative
prognostic factors for several gynecologic malignancies. Multiple factors can cause or …

[HTML][HTML] A genomically characterized collection of high-grade serous ovarian cancer xenografts for preclinical testing

P Cybulska, JM Stewart, A Sayad, C Virtanen… - The American Journal of …, 2018 - Elsevier
High-grade serous ovarian cancer (HGSC) is the leading cause of morbidity and mortality
from gynecologic malignant tumors. Overall survival remains low because of the nearly …

Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?

Y Himoto, P Cybulska, F Shitano, E Sala, J Zheng… - Gynecologic …, 2019 - Elsevier
Purpose To determine if the primary treatment approach (primary debulking surgery (PDS)
versus neoadjuvant chemotherapy and interval debulking surgery (NACT-IDS)) influences …

Teaching cervical cancer surgery in low-or middle-resource countries

…, B Rosen, W Jimenez, C Giede, P Cybulska… - International Journal of …, 2010 - ijgc.bmj.com
Background: With the widespread implementation of screening programs internationally, there
will be an increase in early stage cervical cancer cases. In response to this, the Ministry of …